FDA Seeks Public Comments on Gluten Labelling and Cross-Contamination

The US Food and Drug Administration (FDA) has launched a comprehensive public consultation process to reassess gluten labelling on packaged foods and the risks of cross-contamination in production processes. This initiative aims to maximise food safety, particularly for sensitive consumer groups.

Transparent Labelling and Consumer Safety

The FDA’s call seeks to reinforce the accuracy of ‘Gluten-Free’ claims and eliminate ambiguities in labelling. The agency is seeking technical input from industry stakeholders, scientists, and consumers to ensure the highest level of protection for products consumed by individuals with coeliac disease or gluten intolerance.

What Does This Mean for Food Businesses?

The FDA’s move signals stricter regulations on gluten management and labelling standards in the future. Food manufacturers supplying the global market may need to review their cross-contamination prevention protocols (allergen management) and traceability systems in light of this new scientific data.